Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Transplant Vasculopathy in a Murine Aortic Transplantation Model

Gocht A, Ensminger SM, Distler J, Spriewald B, Ramsperger-Gleixner M, Weyand M, Heim C (2017)

Publication Type: Conference contribution

Publication year: 2017

Journal

Journal of Heart and Lung Transplantation Elsevier

Book Volume: 36

Pages Range: S370-S370

Journal Issue: 4

Authors with CRIS profile

Jörg Distler Professur für Molekulare Mechanismen der Organfibrose Martina Ramsperger-Gleixner Department of Cardiac Surgery Michael Weyand Lehrstuhl für Herzchirurgie Christian Heim Department of Cardiac Surgery

Involved external institutions

Herz- und Diabeteszentrum Nordrhein-Westfalen DE Germany (DE)

How to cite

APA:

Gocht, A., Ensminger, S.M., Distler, J., Spriewald, B., Ramsperger-Gleixner, M., Weyand, M., & Heim, C. (2017). Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Transplant Vasculopathy in a Murine Aortic Transplantation Model. (pp. S370-S370).

MLA:

Gocht, A., et al. "Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Transplant Vasculopathy in a Murine Aortic Transplantation Model." 2017. S370-S370.

BibTeX: Download